Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Atreca (BCEL) stocks in Canada
Learn how to easily invest in Atreca stocks.
Atreca is a biotechnology business based in the US. Atreca stocks (BCEL.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $8.72 – a decrease of 5.75% over the previous week. Atreca employs 137 staff and has a market cap (total outstanding stock value) of $78.8 million.
How to buy shares in Atreca
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BCEL – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Atreca?
- Has coronavirus impacted Atreca shares?
- Atreca shares summary
- Compare share dealing platforms
- Is Atreca stock a buy or sell?
- Atreca performance over time
- Atreca's financials
- How volatile are Atreca shares?
- Does Atreca pay a dividend?
- Have Atreca shares ever split?
- Other common questions
Atreca stock price (NASDAQ:BCEL)Use our graph to track the performance of BCEL stocks over time.
Atreca shares at a glance
|Latest market close||$2.13|
|52-week range||$2.05 - $20.29|
|50-day moving average||$3.77|
|200-day moving average||$6.91|
|Wall St. target price||$20.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.79|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Atreca stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Atreca price performance over time
|1 week (2022-01-13)||-5.75%|
|1 month (2021-12-16)||N/A|
|3 months (2021-10-16)||N/A|
|6 months (2021-07-20)||-74.21%|
|1 year (2021-01-20)||-86.48%|
|2 years (2020-01-17)||-85.65%|
|3 years (2019-01-16)||N/A|
|5 years (2017-01-16)||N/A|
|Gross profit TTM||$0|
|Return on assets TTM||-26.31%|
|Return on equity TTM||-47.09%|
|Market capitalisation||$78.8 million|
TTM: trailing 12 months
Atreca share dividends
We're not expecting Atreca to pay a dividend over the next 12 months.
Have Atreca's shares ever split?
Atreca's shares were split on a 1:6 basis on 6 June 2019. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Atreca shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Atreca shares which in turn could have impacted Atreca's share price.
Atreca share price volatility
Over the last 12 months, Atreca's shares have ranged in value from as little as $2.05 up to $20.29. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Atreca's is -0.0856. This would suggest that Atreca's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Atreca has bucked the trend.
Atreca, Inc. , a biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, and breast cancer samples from multiple patients. It has a collaboration and license agreement with Xencor, Inc. for research, development, and commercialization of novel CD3 bispecific antibodies in oncology. Atreca, Inc.
Stocks similar to Atreca
Atreca in the news
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Joe Manchin's former aides gain influential lobbying clients as their ex-boss battles Biden's agenda
Frequently asked questions
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.